Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients.
Rivero-Juarez A, Tellez F, Castaño-Carracedo M, Merino D, Espinosa N, Santos J, Macias J, Paniagua-García M, Zapata-Lopez A, Collado A, Gómez-Vidal MA, Perez-Stachowski J, Muñoz-Medina L, Fernandez-Fuertes E, Rivero A; Grupo de estudio de Hepatitis virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Rivero-Juarez A, et al. Among authors: macias j. HIV Med. 2019 Jul;20(6):359-367. doi: 10.1111/hiv.12715. Epub 2019 Apr 22. HIV Med. 2019. PMID: 31006980 Free article.
Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta2microglobulin levels.
García-García JA, Mira JA, Fernández-Rivera J, Ramos AJ, Vargas J, Macías J, Pineda JA. García-García JA, et al. Among authors: macias j. Eur J Clin Microbiol Infect Dis. 2003 Mar;22(3):194-6. doi: 10.1007/s10096-003-0888-4. Epub 2003 Mar 1. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12649720 Clinical Trial.
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA. Fernández-Rivera J, et al. Among authors: macias j. HIV Clin Trials. 2003 Sep-Oct;4(5):337-46. doi: 10.1310/4X0H-UVMJ-BHYW-CPFB. HIV Clin Trials. 2003. PMID: 14583850
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis.
Pineda JA, Santos J, Rivero A, Abdel-Kader L, Palacios R, Camacho A, Lozano F, Macías J; Liverey Study Investigator Team. Pineda JA, et al. Among authors: macias j. J Antimicrob Chemother. 2008 Apr;61(4):925-32. doi: 10.1093/jac/dkn045. Epub 2008 Feb 14. J Antimicrob Chemother. 2008. PMID: 18276600
Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients.
Merchante N, Rivero A, de Los Santos-Gil I, Merino D, Márquez M, López-Ruz MA, Rodríguez-Baño J, Del Valle J, Camacho A, Sanz-Sanz J, Macías J, Pérez-Camacho I, Gómez-Mateos J, Moro A, Pineda JA. Merchante N, et al. Among authors: macias j. Gut. 2009 Dec;58(12):1654-60. doi: 10.1136/gut.2009.179085. Epub 2009 Jul 21. Gut. 2009. PMID: 19625279
474 results